Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1294


Current status of the clinical epidemiology of myocardial infarction in men and women: a national cross-sectional study in iran.

Ahmadi A, Soori H, Sajjadi H, Nasri H, Mehrabi Y, Etemad K.

Int J Prev Med. 2015 Feb 20;6:14. doi: 10.4103/2008-7802.151822. eCollection 2015.


Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.

Wang CH, Zhang SY, Fang Q, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ.

Am J Med Sci. 2015 Mar 16. [Epub ahead of print]


Modeling of in hospital mortality determinants in myocardial infarction patients, with and without type 2 diabetes, undergoing pharmaco-invasive strategy: the first national report using two approaches in Iran.

Ahmadi A, Soori H, Sajjadi H.

Diabetes Res Clin Pract. 2015 Mar 1. pii: S0168-8227(15)00118-7. doi: 10.1016/j.diabres.2015.02.018. [Epub ahead of print]


Electrocardiographic prediction of lateral involvement in acute non-anterior wall myocardial infarction.

Norda S, van der Weg K, Vos R, Gorgels AP.

J Electrocardiol. 2015 Feb 24. pii: S0022-0736(15)00054-0. doi: 10.1016/j.jelectrocard.2015.02.005. [Epub ahead of print]


Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease: The CvLPRIT Trial.

Gershlick AH, Khan JN, Kelly DJ, Greenwood JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL, Banya W, Wang D, Flather M, Hetherington SL, Kelion AD, Talwar S, Gunning M, Hall R, Swanton H, McCann GP.

J Am Coll Cardiol. 2015 Mar 17;65(10):963-72. doi: 10.1016/j.jacc.2014.12.038.

Free Article

Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.

Hu X, Huang X, Yang Q, Wang L, Sun J, Zhan H, Lin J, Pu Z, Jiang J, Sun Y, Xiang M, Liu X, Xie X, Yu X, Chen Z, Tse HF, Zhang J, Wang J.

Int J Cardiol. 2015 Feb 25;184C:446-451. doi: 10.1016/j.ijcard.2015.02.084. [Epub ahead of print]


A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: The International MGuard Prime Observational Study (IMOS Prime).

Amoroso G, Vos NS, Van der Heyden JA, van der Schaaf RJ, Patterson MS, Vink MA, Herrman JP, Slagboom T.

Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25914. [Epub ahead of print]


Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 as a Novel Prognostic Biomarker in Patients With ST-Segment Elevation Acute Myocardial Infarction.

Higuma T, Abe N, Tateyama S, Endo T, Shibutani S, Yokoyama H, Hanada K, Yamada M, Tomita H, Hanada H, Osanai T, Kume N, Okumura K.

Circ J. 2015 Feb 25;79(3):641-8. doi: 10.1253/circj.CJ-14-0904. Epub 2015 Jan 23.


Predictors and prognostic consequence of gastrointestinal bleeding in patients with ST-segment elevation myocardial infarction.

Kikkert WJ, Hassell ME, Delewi R, van der Laan MH, Baan J Jr, Vis MM, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP.

Int J Cardiol. 2015 Jan 27;184C:128-134. doi: 10.1016/j.ijcard.2015.01.041. [Epub ahead of print]


Impact of body mass index on the clinical outcomes after percutaneous coronary intervention in patients ≥75 years old.

He PY, Yang YJ, Qiao SB, Xu B, Yao M, Wu YJ, Wu Y, Yuan JQ, Chen J, Liu HB, Dai J, Li W, Tang YD, Yang JG, Gao RL.

Chin Med J (Engl). 2015 Mar 5;128(5):638-43. doi: 10.4103/0366-6999.151662.


[IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (studie IMPROVE-IT)].

Špinar J, Špinarová L, Vítovec J.

Vnitr Lek. 2014 Dec;60(12):1095-101. Czech.


One-year clinical outcomes of the STENTYS Self-Apposing® coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.

Koch KT, Grundeken MJ, Vos NS, IJsselmuiden AJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JG, Amoroso G.

EuroIntervention. 2015 Feb 19;10(11). pii: 20140518-01. doi: 10.4244/EIJY15M02_08. [Epub ahead of print]


Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.

Szummer K, Oldgren J, Lindhagen L, Carrero JJ, Evans M, Spaak J, Edfors R, Jacobson SH, Andell P, Wallentin L, Jernberg T.

JAMA. 2015 Feb 17;313(7):707-16. doi: 10.1001/jama.2015.517.


Serial changes of mean platelet volume in relation to Killip Class in patients with acute myocardial infarction and primary percutaneous coronary intervention.

Wang XY, Yu HY, Zhang YY, Wang YP, Feng XH, Li ZP, Du XJ, Gao W.

Thromb Res. 2015 Apr;135(4):652-8. doi: 10.1016/j.thromres.2015.01.033. Epub 2015 Feb 4.


Vorapaxar in Atherosclerotic Disease Management.

Cheng JW, Colucci V, Howard PA, Nappi JM, Spinler SA.

Ann Pharmacother. 2015 Feb 13. pii: 1060028015571410. [Epub ahead of print] Review.


Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial.

Ng VG, Lansky AJ, Toro S, Parise H, Cristea E, Mehran R, Stone GW.

Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25865. [Epub ahead of print]


Relation of In-hospital Serum Creatinine Change Patterns and Outcomes Among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

Shacham Y, Leshem-Rubinow E, Gal-Oz A, Ben-Assa E, Steinvil A, Keren G, Roth A, Arbel Y.

Clin Cardiol. 2015 Feb 1. doi: 10.1002/clc.22384. [Epub ahead of print]


One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study.

Thomas MR, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood PL, Dawkins KD.

EuroIntervention. 2015 Mar 22;10(11):1267-71. doi: 10.4244/EIJY15M01_07.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk